We use cookies to give you the best possible experience with eirhub.eu. Some are essential for this site to function; others help us understand how you use the site, so we can improve it. We may also use cookies for targeting purposes. Click “Accept all cookies” to proceed as specified, or click “Manage my preferences” to choose the types of cookies you will accept. Cookie policy
Privacy Preference Center
Eirhub and our trusted partners use cookies and similar technologies to access and use your data for the purposes listed below. Please provide your consent for cookie usage on this website. Enable one or more of the cookie types listed below, and then save your preferences. Cookie policy
Manage Consent Preferences
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Active (Inactive)
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Active (Inactive)
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Active (Inactive)
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. Always Active

Short Bowel Syndrome—Pre-Market Entry Study

To assess the opportunity of accessing the local market.
To assess the opportunity of accessing the local market.
EU-based Market Access consultancy.
Product in focus:

Teduglutide brand—the first and only long-term therapy indicated for the treatment of patients with SBS-IF (orphan disease).

Project areas:
  • Analysis of the country's short bowel syndrome-intestinal failure (SBS-IF) market.
  • Assessment of the existing competitive environment in the core market.
  • Identification of the total patient population for the targeted indication.
  • Estimation of time to achieve public funding.
  • Overview of the public funding of medicines in Ukraine.
  • Overview of the situation concerning the country's public funding of orphan drugs.
  • Mapping decision-makers in the area of demand forming for orphan drugs in Ukraine.‍
  • Detailed report on the Short Bowel Syndrome in Ukraine.
  • Regulatory environment overview.
  • Pricing & Reimbursement status.
  • Map of key stakeholders and decision-makers.


Yevgen Brovko
Co-founder, Market Access Partner (Pharmac/Biopharma, MedTech, Digital Health)
our Brochure